Frequency and characterisation of stroke rehabilitation in an unselected group of young stroke patients with Fabry disease

Completed

• Conditions: Fabry disease and stroke; Nutritional, Metabolic, Endocrine; Disorders of sphingolipid metabolism and other lipid storage disorders

• Registration Number: ISRCTN26016503
• Lead Sponsor: Albrecht-Kossel-Institute for Neuroregeneration (Germany)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-02-27
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

1. Adult patients (18 - 55 years of age, either sex) with an acute cerebrovascular event of any aetiology defined as patients having an acute ischaemic stroke or transient ischaemic attack less than 3 months before enrolment into the study
2. Magnetic resonance imaging (MRI)-scan evidence of associated corresponding brain infarction or haemorrhage, regardless of the duration of symptoms. Alternatively also patients with no signs of stroke in the MRI can be included if a stroke-experienced neurologist has done the initial diagnosis as ischaemic stroke, transient ischaemic attack or haemorrhage.
3. Detailed MRI documentation at admission to entry to the study
4. Diagnostic procedures for CVE according to the European Stroke Initiative (EUSI) recommendations
5. Written informed consent from patient or legal representative according to local regulations

Exclusion Criteria

1. Patients being younger than 18 years or older than 55 years of age
2. Acute ischaemic stroke or transient ischaemic attack longer than 3 months before enrolment into the study
3. Diagnosis of the 3-month lasting CVE has been done by a non-neurologist if there is no MRI-scan evidence of associated brain infarction or haemorrhage
4. No detailed MRI documentation at admission to entry to the study

Study & Design

• Study Type: Observational
• Study Design: Not specified